featured
Management of Rare RCC Subtypes - Translocation RCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
elvina almuradova
Xp11.2 translocation renal cell carcinomas, mutated TFE3 gene leads to upregulation of the mesenchymal-epithelial transition (MET) Thus met inhibitors can be used in treatment